Reconstituting CJC-1295 Without DAC: Step-by-Step Laboratory Protocol

Reconstituting CJC-1295 Without DAC: Step-by-Step Laboratory Protocol

Reconstituting CJC-1295 Without DAC: Step-by-Step Laboratory Protocol

CJC-1295 without DAC represents a synthetic analog of growth hormone-releasing hormone (GHRH) designed for in vitro research applications. This modified peptide sequence contains 29 amino acids and demonstrates enhanced stability compared to native GHRH while maintaining biological activity in laboratory settings. The lyophilized formulation requires precise reconstitution techniques to preserve peptide integrity and ensure consistent research outcomes across experimental protocols.

Required Laboratory Materials

CJC-1295 Without DAC 2mg lyophilized vial from Element SARMs

Bacteriostatic water for injection (BWFI) or sterile water for injection

Sterile syringes (1mL and 3mL capacity)

Sterile needles (25-gauge or smaller)

Alcohol swabs (70% isopropyl alcohol)

Laminar flow hood or sterile work environment

Analytical balance (0.1mg precision minimum)

Sterile glass vials for aliquoting

Laboratory marker for labeling

Disposable gloves and laboratory coat

Pre-Reconstitution Laboratory Preparation

Establish a sterile working environment within a laminar flow hood to minimize contamination risk during peptide reconstitution. Allow the lyophilized CJC-1295 vial to equilibrate to room temperature for approximately 15 minutes before handling. Verify that all reconstitution materials are sterile and within expiration dates. Prepare the workspace by cleaning all surfaces with 70% isopropyl alcohol and arranging materials in order of use to maintain aseptic technique throughout the procedure.

Calculate the desired final concentration based on experimental requirements. For research applications involving cell culture studies, concentrations ranging from 1-10 μg/mL are commonly utilized, while biochemical assays may require different concentration ranges depending on assay sensitivity and detection methods.

Reconstitution Procedure

Step 1: Remove the plastic cap from the CJC-1295 vial and clean the rubber stopper thoroughly with an alcohol swab. Allow the alcohol to evaporate completely before proceeding to maintain sterile conditions.

Step 2: Using aseptic technique, draw the calculated volume of bacteriostatic water into a sterile syringe. For initial reconstitution, 1mL of solvent will yield a 2mg/mL stock concentration suitable for further dilution.

Step 3: Insert the needle through the rubber stopper at a slight angle to minimize coring. Direct the needle toward the side wall of the vial rather than directly onto the lyophilized peptide cake to prevent foaming and potential peptide degradation.

Step 4: Slowly inject the solvent along the vial wall, allowing it to gently dissolve the peptide powder. Avoid creating excessive turbulence or bubbles during this process as mechanical stress can damage peptide structure.

Step 5: Withdraw the needle and gently swirl the vial in a circular motion to facilitate complete dissolution. Do not shake vigorously or vortex the solution, as this may denature the peptide through mechanical stress.

Step 6: Allow the solution to stand for 2-3 minutes to ensure complete dissolution before use. The resulting solution should be clear and colorless without visible particulates or precipitation.

Concentration Options

1.0 mL

2.0 mg/mL

Stock solution for dilution

2.0 mL

1.0 mg/mL

Intermediate concentration

4.0 mL

0.5 mg/mL

Working solution

Storage Conditions and Stability

Store reconstituted CJC-1295 solutions at 2-8°C in sterile containers protected from light exposure. When using bacteriostatic water as the reconstitution solvent, solutions maintain stability for up to 30 days under proper refrigeration conditions. For extended storage periods exceeding one week, consider aliquoting the solution into smaller volumes to minimize repeated freeze-thaw cycles that may compromise peptide integrity.

For long-term storage, the reconstituted peptide may be stored at -20°C for up to six months. Avoid repeated freezing and thawing by preparing single-use aliquots appropriate for individual experimental procedures.

Research Application Notes

Element SARMs' CJC-1295 Without DAC proves particularly valuable in growth hormone research protocols, receptor binding studies, and signal transduction pathway investigations. The reconstituted peptide demonstrates optimal performance in cell culture applications when diluted to working concentrations immediately before use. Researchers should validate peptide activity through appropriate positive controls and establish baseline parameters for their specific experimental systems before conducting extensive studies.

All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.

Hexarelin

TB-500

Epithalon

Ipamorelin

Tirzepatide

CJC-1295 DAC

PT-141

Semaglutide

Selank

BPC-157

Sermorelin

Melanotan 2

IGF LR3

Tesamorelin

AICAR

IGF-DES

GHRP 2

Albuterol

Tamoxifen

Letrozole

Clomiphene

Tadalafil

Clenbuterol

Anastrozole

Finasteride

Exemestane

Sildenafil

Yohimbine

Bacteriostatic Water Recent Posts Melanotan 2 (MT2): Mechanism, Research, and Safety Considerations Ipamorelin: The Selective GHRP, Explained Tesamorelin: The GHRH Analog Studied for Visceral Fat Sermorelin: The Original GHRH Analog, Explained CJC-1295: How the GHRH Analog Works, and What Research Shows

Already a customer? Sign In

Create Account

All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.

ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.

Sarms

Stacks

Research Liquids

Albuterol 5MG/ML | 30ML with dropper

Anastrozole 1.5MG/ML | 30ML with dropper

Clomiphene 50MG/ML | 30ML with dropper

Finasteride 5MG/ML | 30ML with dropper

Letrozole 3.5 MG/ML | 30ML with dropper

LiquiCia 30MG/ML | 30ML with dropper

LiquiCia T50 50MG/ML | 30ML with dropper

LiquiClen 200MCG/ML | 30ML with dropper

Liquistane / Exemestane 25MG/ML | 30ML with dropper

LiquiTamo 20MG/ML | 30ML with dropper

LiquiVia 25MG/ML | 30 ML with dropper

T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper

Toremifene Citrate 60MG/ML | 30ML with dropper

Yohimbine HCL 10MG/ML | 30ML with dropper

Research Peptides

Aicar 50MG

BPC-157 + TB-500 Blend 2mg ea/ 4MG

BPC-157 5MG

CJC-1295 + DAC 2MG

CJC-1295 | No DAC 2MG

Epithalon 10MG

Frag Premium 176-191 5MG

GHK-CU Copper Peptide 50MG

GHRP-2 5MG

GHRP-6 5MG

Hexarelin 5MG

IGF-1 DES 1MG

IGF-1 LR3 1MG

Ipamorelin 5MG

Melanotan 2 10MG

NAD+ 500MG

PT-141 / Bremelanotide 10MG

GLP-1/GIP/GCG (RT)

Selank 5MG

GLP1 (SM)

Sermorelin 5MG

TB-500 5MG

GIP/GLP-1 (TZ)

PDE5 Inhibitors

GLP-1

Diluents

Bacteriostatic Water 10ML